Tuning the Biological Activity of RGD Peptides with Halotryptophans

Abstract

An array of l- and d-halotryptophans with different substituents at the indole moiety was synthesized employing either enzymatic halogenation by halogenases or incorporation of haloindoles using tryptophan synthase. Introduction of these Trp derivatives into RGD peptides as a benchmark system was performed to investigate their influence on bioactivity. Halotryptophan-containing RGD peptides display increased affinity toward integrin α_vβ₃ and enhanced selectivity over integrin α₅β₁. In addition, bromotryptophan was exploited as a platform for late-stage diversification by Suzuki-Miyaura cross-coupling (SMC), resulting in new-to-nature biaryl motifs. These peptides show enhanced affinity toward α_vβ₃, good affinity to α_vβ₈, and remarkable selectivity over α₅β₁ and α_IIbβ₃ while featuring fluorogenic properties. Their feasibility as a probe was demonstrated <i>in vitro</i>. Extensive molecular dynamics simulations were undertaken to elucidate NMR and high-performance liquid chromatography (HPLC) data for these late-stage diversified cyclic RGD peptides and to further characterize their conformational preferences.